IMBA - Institute of Molecular Biotechnology
The establishment of self-organizing heart organoids called cardioids, at IMBA – Institute of Molecular Biotechnology of the Austrian Academy of...
An important pillar in the fight against the Covid-19 pandemic is accurate, rapid and frequent testing for the coronavirus SARS-CoV-2, for example,...
On Thursday a special visit to the IMBA and the Vienna Open Lab presented the most important cornerstones of the new Research Funding Act. Anton...
Jürgen Knoblich, Scientific Director of IMBA – Institute of Molecular Biotechnology of the Austrian Academy of Sciences – is now part of the Board of...
An international team of researchers with the participation of IMBA - Institute of Molecular Biotechnology of the Austrian Academy of Sciences -...
IMBA is part of the MAD-CoV 2 project and is funded with 1.1 Million Euros by the European Commission for developing antivirals against SARS-CoV-2.
Senior Communications Manager
+43 1 79044 - 3628
Head of Communications
+43 699 12300904
The Vienna Science, Research and Technology Fund (WWTF) supports Viennese universities and research institutions with "COVID-19 Rapid Response...
SARS-CoV-2, the virus causing coronavirus disease-19 (COVID-19), is spreading worldwide at a fast pace. In a concerted effort including researchers...
In a new study published in the Journal Science Advances, the Bell lab at IMBA reveals how multiple highly-conserved chromatin modifying complexes...
Page 1 of 29.
Click on „Cookie-Preferences“ to change the cookie settings manually.